Jpmorgan Chase & Co »

Checkpoint Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Checkpoint Therapeutics (CKPT) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Checkpoint Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Checkpoint Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Checkpoint Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $2 1 2.00
2023-09-30 $65 39 1.69
2023-06-30 $2 1 2.00
2023-03-31 $0 1 0.00
2022-12-31 $0 1 0.00